Alpha Tau Medical
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Public
- Established
- 2016-01-01
- Employees
- 121
- Market Cap
- -
- Website
- http://www.alphatau.com
- Introduction
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma
Not Applicable
Not yet recruiting
- Conditions
- Recurrent GlioblastomaRecurrent Gliomas
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 10
- Registration Number
- NCT06910306
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer
Not Applicable
Not yet recruiting
- Conditions
- Pancreatic CancerLocally Advanced Pancreatic Cancer
- First Posted Date
- 2025-01-01
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 40
- Registration Number
- NCT06755359
- Locations
- 🇫🇷
CHU de Bordeaux, Bordeaux, France
🇫🇷Centre Jean PERRIN - Clermont-Ferrand, Clermont-Ferrand, France
🇫🇷Centre Georges François Leclerc Dijon, Dijon, France
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
Not Applicable
Not yet recruiting
- Conditions
- Pancreatic CancerPancreatic AdenocarcinomaMetastatic Pancreatic Cancer
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 30
- Registration Number
- NCT06698458
Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients
Not Applicable
Not yet recruiting
- Conditions
- Squamous Cell CarcinomaAlpha RadiationImmunocompromisedCarcinoma, SquamousSkin CancerBrachytherapy
- Interventions
- Device: DaRT seeds
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 28
- Registration Number
- NCT06615635
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.
Not Applicable
Recruiting
- Conditions
- Recurrent Breast CancerBreast CancerBreast Carcinoma
- Interventions
- Device: Diffusing Alpha Radiation Emitters Therapy (DaRT)
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 10
- Registration Number
- NCT06202118
- Locations
- 🇮🇱
Hadassah Medical Center, Jerusalem, Israel
A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer
Not Applicable
Recruiting
- Conditions
- Locally Recurrent Prostate CancerNon-metastatic Prostate Cancer
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 10
- Registration Number
- NCT06202248
- Locations
- 🇮🇱
RAMBAM Health Care Campus, Haifa, Israel
Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).
Not Applicable
Not yet recruiting
- Conditions
- Carcinoma of the VulvaRecurrent Carcinoma of the Vulva
- Interventions
- Device: DaRT seeds
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 10
- Registration Number
- NCT06202339
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer
Not Applicable
Not yet recruiting
- Conditions
- Unresectable Pancreatic CancerPancreatic CancerPancreatic Adenocarcinoma
- Interventions
- Device: DaRT seeds insertion
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 15
- Registration Number
- NCT06026943
Alpha Radiation Emitters Device for the Treatment of Liver Metastases (DaRT)
Not Applicable
Recruiting
- Conditions
- Liver Metastases
- Interventions
- Device: Diffusing Alpha Radiation Emitters Therapy (DaRT)
- First Posted Date
- 2023-04-25
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 10
- Registration Number
- NCT05829291
- Locations
- 🇨🇦
e McGill University Health Centre (MUHC), Montréal, Quebec, Canada
A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors
Not Applicable
Recruiting
- Conditions
- Malignant Tumor
- First Posted Date
- 2023-03-23
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 100
- Registration Number
- NCT05781555
- Locations
- 🇮🇱
Hadassah Ein Kerem, Jerusalem, Israel
© Copyright 2025. All Rights Reserved by MedPath